REFERENCES
- Waters A, Beales P. Bardet-Biedl Syndrome, 2010.
- Sears J, Capone A, Jr, Aaberg T, Sr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology 1999;106:920–924.
- Lee JE, Gleeson JG. Cilia in the nervous system: linking cilia function and neurodevelopmental disorders. Curr Opin Neurol 2011;24:98–105.
- Zaghloul NA, Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest 2009;119:428–437.
- Azari AA, Aleman TS, Cideciyan AV, et al. Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration. Invest Ophthalmol Vis Sci 2006;47:5004–5010.
- Gerth C, Zawadzki RJ, Werner JS, Heon E. Retinal morphology in patients with BBS1 and BBS10 related Bardet-Biedl Syndrome evaluated by Fourier-domain optical coherence tomography. Vision Res 2008;48:392–399.
- Brosnahan DM, Kennedy SM, Converse CA, Lee WR, Hammer HM. Pathology of hereditary retinal degeneration associated with hypobetalipoproteinemia. Ophthalmology 1994;101:38–45.
- Duvall J, McKechnie NM, Lee WR, Rothery S, Marshall J. Extensive subretinal pigment epithelial deposit in two brothers suffering from dominant retinitis pigmentosa. A histopathological study. Graefes Arch Clin Exp Ophthalmol 1986;224:299–309.
- Malik A, Sood S, Narang S. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab. Int Ophthalmol 2010;30:425–428.